UK sees a 20% growth in the number of advanced therapy trials, report finds by Lucy Parsons | Feb 23, 2021 | News | 0 Cell and Gene Therapy Catapult report also found a surge in the number of commercially sponsored trials Read More
EMA PRIME status granted to Janssen’s inherited retinal disease gene therapy by Anna Smith | Mar 3, 2020 | News | 0 The designation makes the drug the only XLRP treatment in development to be awarded PRIME designation. Read More